4
Changes in Ownership
Roivant Sciences Ltd. Filed Acc 0001140361-23-049763
CEO disposed of 12,489 shares (other)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gline Matthew CEO | 2023-10-24 | Other disposition 10b5-1 | −12,489 | $8.99 | $112,276 | 1,028,751 | D: show line 1 in the form |
Loading xslF345X05/form4.xml…